A detailed history of Janus Henderson Group PLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Janus Henderson Group PLC holds 24,296 shares of PRCT stock, worth $2.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,296
Previous 18,521 31.18%
Holding current value
$2.32 Million
Previous $915,000 62.19%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$45.73 - $69.19 $264,090 - $399,572
5,775 Added 31.18%
24,296 $1.48 Million
Q1 2024

May 15, 2024

BUY
$40.38 - $50.75 $40 - $50
1 Added 0.01%
18,521 $915,000
Q4 2023

Feb 14, 2024

SELL
$24.89 - $43.41 $1,393 - $2,430
-56 Reduced 0.3%
18,520 $776,000
Q3 2023

Nov 14, 2023

BUY
$30.02 - $38.81 $810 - $1,047
27 Added 0.15%
18,576 $609,000
Q2 2023

Aug 14, 2023

BUY
$26.7 - $37.02 $495,258 - $686,683
18,549 New
18,549 $655,000

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $4.26B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.